Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE)

NCT04705142 is registered in ClinicalTrials.gov with Services Institute of Medical Sciences, Pakistan as lead sponsor.

NCT NCT04705142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04705142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE)
Lead sponsor
Services Institute of Medical Sciences, Pakistan
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2019
Completion date
December 30, 2020
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hie